Posted by Granville Matheson on Wednesday, August 1, 2018



  • Matheson GJ (2019). We need to talk about reliability: Making better use of test retest studies for study design and interpretation. PeerJ, 7, e6918.

  • Matheson GJ*, Plavén-Sigray P*, Tuisku J, Rinne J, Matuskey D & Cervenka S (in press). Clinical Brain PET Research must Embrace Multi-Centre Collaboration and Data Sharing or Risk its Demise . European Journal of Nuclear Medicine and Molecular Imaging.

  • Matheson GJ (2019). kinfitr: Reproducible PET Pharmacokinetic Modelling in R. bioRxiv, 755751.

  • Stenkrona P, Matheson GJ, Halldin C, Cervenka S & Farde L (2019). D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients. International Journal of Neuropsychopharmacology, 22(7), 415-425.


  • Matheson GJ, Plavén-Sigray P, Louzolo Anaïs, Borg J, Farde L, Petrovic P & Cervenka S (2018). Dopamine D1 receptor availability is not associated with delusional ideation measures of psychosis proneness. bioRxiv, 321646.

  • Plavén-Sigray P, Matheson GJ, Gustavsson P, Stenkrona P, Halldin C, Farde L & Cervenka S (2018). Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study. PloS one, 13, e0193770.

  • Plavén-Sigray P, Matheson GJ, Cselényi Z, Jucaite A, Farde L & Cervenka S (2018). Test-retest reliability and convergent validity of (R)-[11C] PK11195 outcome measures without arterial input function. EJNMMI Research, 8, 102.

  • Plavén-Sigray P, Matheson GJ, Collste K, Ashok AH, Coughlin JM, Howes OD, Mizrahi R, Pomper MG, Rusjan P, Veronese M & others (2018). Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data. Biological psychiatry, 84.

  • Griffioen G, Matheson GJ, Cervenka S, Farde L & Borg J (2018). Serotonin 5-HT1A receptor binding and self-transcendence in healthy control subjects-a replication study using Bayesian hypothesis testing. PeerJ, 6, e5790.

  • Caravaggio F, Plavén-Sigray P, Matheson GJ, Plitman E, Mallar Chakravarty M, Borg J, Graff-Guerrero A & Cervenka S (2018). Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy men. PloS one, 13(12), e0209584.

  • Stenkrona P, Matheson GJ, Cervenka S, Plavén-Sigray P, Halldin C & Farde L (2018). [11C] SCH23390 binding to the D1-dopamine receptor in the human brain-a comparison of manual and automated methods for image analysis. EJNMMI research, 8, 74.


  • Matheson GJ, Stenkrona P, Cselényi Z, Plavén-Sigray P, Halldin C, Farde L & Cervenka S (2017). Reliability of volumetric and surface-based normalisation and smoothing techniques for PET analysis of the cortex: A test-retest analysis using [11 C] SCH-23390. NeuroImage, 155, 344-353.

  • Matheson GJ, Plavén-Sigray P, Forsberg A, Varrone A, Farde L & Cervenka S (2017). Assessment of simplified ratio-based approaches for quantification of PET [11 C] PBR28 data. EJNMMI research, 7, 58.

  • Plavén-Sigray P*, Matheson GJ*, Schiffler BC* & Thompson WH (2017). The readability of scientific texts is decreasing over time. eLife, 6.

  • Plavén-Sigray P, Hedman E, Victorsson P, Matheson GJ, Forsberg A, Djurfeldt Diana R, Rück C, Halldin C, Lindefors N & Cervenka S (2017). Extrastriatal dopamine D2-receptor availability in social anxiety disorder. European Neuropsychopharmacology, 27, 462-469.


  • Borg J, Cervenka S, Kuja-Halkola R, Matheson GJ, Jönsson EG, Lichtenstein P, Henningsson S, Ichimiya T, Larsson H, Stenkrona P & others (2016). Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain. Molecular psychiatry, 21, 1077-1084.


  • Matheson GJ, Schain M, Almeida R, Lundberg J, Cselényi Z, Borg J, Varrone A, Farde L & Cervenka S (2015). Diurnal and seasonal variation of the brain serotonin system in healthy male subjects. NeuroImage, 112, 225-231.

* = shared first-authorship

comments powered by Disqus